Absalyamova, O., Kobiakov, G., Agabekyan, G., Poddubsky, A., Belyashova, A., Lodygina, K., . . . Kobiakov, N. (2019). P14.15 Benefit of Bevacizumab for recurrent glioblastoma. Results of 81 patients from a single institution. Neuro Oncol.

Absalyamova, O., G. Kobiakov, G. Agabekyan, A. Poddubsky, A. Belyashova, K. Lodygina, A. Absalyamov, et N. Kobiakov. "P14.15 Benefit of Bevacizumab for Recurrent Glioblastoma. Results of 81 Patients From a Single Institution." Neuro Oncol 2019.

Absalyamova, O., et al. "P14.15 Benefit of Bevacizumab for Recurrent Glioblastoma. Results of 81 Patients From a Single Institution." Neuro Oncol 2019.